Investing Profile

Robert Nelsen

VCInvestor

Co-founder and a Managing Director of ARCH Venture Partners

Photo of Robert Nelsen, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$75.0M
63
$635.8M
CompanyStageDateRound SizeTotal Raised
Be Biopharma
Series BApr 2022$130M
$130M
Recuro Health
Convertible NoteMar 2022
Series AAug 2021$15M
$15M
LifeMine Therapeutics
Series CMar 2022$180M
Series ASep 2017$70M
$250M
Co-investors: Krishna Yeshwant (GV), Jim Tananbaum (Foresite Capital)
Nutcracker Therapeutics
Series CMar 2022$170M
Series BSep 2020$60M
$230M
Colossal Biosciences
Series AMar 2022$60M
$75M
Co-investors: Tom Chi (At One Ventures), Thomas Tull, Jeffrey Wilke
Gameto
Series AJan 2022$20M
$23M
Co-investors: Jack Abraham (Atomic), Steve Jurvetson (Future Ventures), Anne Wojcicki
Neumora Therapeutics
Series AOct 2021$400M
$400M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Kristina Burow (ARCH Venture Partners)
Sonoma BioTherapeutics
Series BAug 2021$270M
Series ASep 2020$30M
Series AFeb 2020$40M
$340M